Should I buy Align Technology (ALGN) stock or is it too late?

Align Technology · Health Care · price $144

See the full Align Technology (ALGN) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Stifel — 68% of its targets hit on this sector (304 calls tested). It aims for $175 (+22 %), call made on October 10, 2026, maturing on October 10, 2027 (4 d ago).

The 3 reliable analysts $175+22 %

The 5 other firms $220+53 %

How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $175 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Align Technology

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Jefferies	89 %	+31.8 %	9	$140 -2%
Stifel	60 %	+27.8 %	40	$175 +22%
Baird	62 %	+25.4 %	16	$276 +92%
Barclays	60 %	+9.5 %	5	$200 +39%
Morgan Stanley	56 %	+9.4 %	18	$188 +31%
UBS	50 %	+5.7 %	6	$189 +32%
Piper Sandler	36 %	-6.3 %	33	$235 +64%
Evercore ISI Group	36 %	-13.1 %	14	$155 +8%

In short — Should you invest in Align Technology? Is it too late, still worth it? Analysts are fairly positive (57% buy, median target $189, i.e. +32%), and the most reliable on ALGN targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $189, i.e. +32% from the current price ($144).
The most reliable firm on ALGN, Mizuho (100% hit rate, 2 scored calls), targets $220 (call made on April 30, 2026, maturing on April 30, 2027) (+53%) in its most recent call, and $200 (call made on January 20, 2026, maturing on January 20, 2027) (+39%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 7 ratings, 3 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on ALGN

Median target $189 (+32%) · 7 ratings · Buy consensus

Strong Buy00%

Buy457%

Hold343%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Align Technology now?

We won't decide for you. The facts: 57% of analysts rate it a buy, median target $189 (+32%), and Mizuho (most reliable on ALGN, 100%) targets $220. Weigh that against valuation (P/E ~24). This is not personalized advice.

Is it too late to invest in Align Technology?

Not according to analysts: the median target ($189) is still +32% above the current price ($144) (most reliable on ALGN: Mizuho, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Align Technology still worth investing in?

It depends on the gap between the price ($144) and its estimated value: analysts target $189 on median (+32%), with 57% buys (most reliable on ALGN: Mizuho, 100%). Cross-check with their real reliability on ALGN and the cautions above. Information, not advice.

What's the main risk in buying ALGN?

The consensus is not unanimous: of 7 ratings, 3 are neutral.

→ Go deeper: the full Align Technology profile (consensus, analyst reliability, price target, performance).